- Home
- PRPO vs DRIO Comparison
PRPO vs DRIO Comparison
Compare PRPO & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- DRIO
- Stock Information
- Founded
- PRPO N/A
- DRIO 2011
- Country
- PRPO United States
- DRIO United States
- Employees
- PRPO N/A
- DRIO N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- DRIO Medical/Dental Instruments
- Sector
- PRPO Industrials
- DRIO Health Care
- Exchange
- PRPO Nasdaq
- DRIO Nasdaq
- Market Cap
- PRPO 22.0M
- DRIO 23.5M
- IPO Year
- PRPO N/A
- DRIO N/A
- Fundamental
- Price
- PRPO $13.80
- DRIO $0.50
- Analyst Decision
- PRPO
- DRIO Strong Buy
- Analyst Count
- PRPO 0
- DRIO 2
- Target Price
- PRPO N/A
- DRIO $2.50
- AVG Volume (30 Days)
- PRPO 7.2K
- DRIO 154.7K
- Earning Date
- PRPO 08-14-2025
- DRIO 08-12-2025
- Dividend Yield
- PRPO N/A
- DRIO N/A
- EPS Growth
- PRPO N/A
- DRIO N/A
- EPS
- PRPO N/A
- DRIO N/A
- Revenue
- PRPO $20,029,000.00
- DRIO $28,034,000.00
- Revenue This Year
- PRPO N/A
- DRIO $20.85
- Revenue Next Year
- PRPO N/A
- DRIO $17.09
- P/E Ratio
- PRPO N/A
- DRIO N/A
- Revenue Growth
- PRPO 26.67
- DRIO 47.20
- 52 Week Low
- PRPO $3.90
- DRIO $0.50
- 52 Week High
- PRPO $16.89
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- PRPO 49.26
- DRIO 26.12
- Support Level
- PRPO $13.92
- DRIO $0.51
- Resistance Level
- PRPO $14.65
- DRIO $0.60
- Average True Range (ATR)
- PRPO 0.38
- DRIO 0.05
- MACD
- PRPO -0.21
- DRIO -0.01
- Stochastic Oscillator
- PRPO 0.00
- DRIO 1.35
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.